Jed Black

Publication Details

  • Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.

    Black JE, Hirshkowitz M. Sleep. 2005; 28 (4): 464-71

    Nasal continuous positive airway pressure (nCPAP) usually reduces sleepiness in patients with obstructive sleep apnea/hypopnea syndrome. However, even with regular use of nCPAP, some patients experience residual excessive sleepiness. We evaluated the efficacy and safety of the wake-promoting agent modafinil for treating residual excessive sleepiness in nCPAP-treated patients.

    PubMedID: 16171291

Stanford Medicine Resources:

Footer Links: